Sage Therapeutics' financials indicate a need for additional funding in 2025, risking dilution and further financial ...

The DRDC have the first set of animals (soman controls and bucillamine pretreated) completed and is now performing the assays looking at GABA receptor downregulation. Over the next few weeks data will ...

Alcohol suppresses excitatory signals while enhancing gamma-aminobutyric acid (GABA), the main inhibitory neurotransmitter in ...

These non-alcoholic beverages include ingredients like nootropics and adaptogens which may boost your mood — without the ...

Experts say there’s been a rise in young people taking 'Xanax' recreationally in Australia. The drug is usually prescribed to ...

DHM is a flavonoid that is being marketed as a hangover remedy. However, DHM's effectiveness remains unproven. Early studies suggest DHM may protect against alcohol-related liver damage, but these ...

By one estimate, 68% of Americans consume less than the recommended dietary amount of magnesium. Magnesium is essential for ...

The global burden of anxiety- and depression-related disorders is on the rise. While multiple drugs have been developed to treat these conditions, current medications have several limitations, ...

Sage Therapeutics, Inc. today announced that Chief Executive Officer Barry Greene will discuss the Company's strategic focus areas for 2025 at the 43rd Annual J.P. Morgan Healthcare Conference in San ...

Depression continues to grapple a large proportion of the population. Given the side effects associated with the long-term ...

Many alcohol companies have delved into the realm of alcohol-free versions; even Guinness has released a 0% brew.

Plus, some people experience unpleasant side effects when supplementing magnesium, like nausea and stomach cramps. Therefore, ...